LENZ Therapeutics Inc LENZ:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
16.35UNCH (UNCH)
Volume
150,154
Close
16.35quote price arrow down-0.18 (-1.09%)
Volume
168,855
52 week range
14.07 - 29.82
Loading...
  • Open16.50
  • Day High17.25
  • Day Low16.21
  • Prev Close16.53
  • 52 Week High29.82
  • 52 Week High Date03/11/24
  • 52 Week Low14.07
  • 52 Week Low Date11/15/23

Key Stats

  • Market Cap417.488M
  • Shares Out25.53M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-10.85

KEY STATS

  • Open16.50
  • Day High17.25
  • Day Low16.21
  • Prev Close16.53
  • 52 Week High29.82
  • 52 Week High Date03/11/24
  • 52 Week Low14.07
  • 52 Week Low Date11/15/23
  • Market Cap417.488M
  • Shares Out25.53M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change-10.85

RATIOS/PROFITABILITY

  • EPS (TTM)-15.88
  • P/E (TTM)-1.03
  • Fwd P/E (NTM)-8.19
  • EBITDA (TTM)-63.535M
  • ROE (TTM)-49.48%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On LENZ Therapeutics Inc

 

Profile

MORE
LENZ Therapeutics, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia. Its product candidates, LNZ100 and LNZ101, are preservative-free, single-use, once-daily eye drops containing aceclidine and aceclidine plus brimonidine, respectively. LNZ100 and LNZ101 are under clinical evaluation in the registration-enabling Phase III CLARITY trials as...
Address
445 Marine View Ave Suite 320
Del Mar, CA
92014
United States

Top Peers

SYMBOLLASTCHG%CHG
TRVI
Trevi Therapeutics Inc
2.77-0.07-2.46%
INMB
INmune Bio Inc
10.85-0.32-2.86%
KOD
Kodiak Sciences Inc
3.30-0.44-11.76%
GALT
Galectin Therapeutics Inc
3.23+0.09+2.87%
ATOS
Atossa Therapeutics Inc
1.57-0.04-2.48%